Rho-inhibition and neuroprotective effect on rotenone-treated dopaminergic neurons in vitro
Abstract
Mesencephalic cell cultures are a good model to study the vulnerability of dopaminergic neurons and reproduce, in vitro, experimental models of Parkinson's disease. Rotenone associated as an environmental neurotoxin related to PD, is able to provoke dopaminergic neuron degeneration by inhibiting complex I of the mitochondrial respiratory chain and by inducing accumulation of α-synuclein. Recently, rotenone has been described to activate RhoA, a GTPase protein. In the present study we evaluated a possible neuroprotective effect of Rho-inhibitor molecules on rotenone-damaged dopaminergic (DA) neurons obtained from mouse primary mesencephalic cell culture. Our results showed that Clostridium Botulinum C3 toxin (C3) and simvastatin, as RhoA inhibitors, were able to protect DA neurons from rotenone damages. In fact, pretreatment with C3 or simvastatin significantly prevented the reduction of [ 3 H]dopamine uptake, neurites injury and the expression patterns of proteins like α-syn, actin and connexin 43.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Rotenone treatment of primary mouse mesencephalic cultures increases RhoA activity, and RhoA inhibition using either C3 transferase or Simvastatin protects dopaminergic neurons against rotenone-induced neurite damage.
“Similarly, rotenone treatment of primary mouse mesencephalic cultures increased RhoA activity, and RhoA inhibition using either C3 transferase or Simvastatin protected the dopaminergic neurons against rotenone-induced neurite damage [177].”
From RhoA Signaling in Neurodegenerative Diseases (2022) · cites this paper as [177]
Cited by
Sorted by citations
RhoA Signaling in Neurodegenerative Diseases
Schmidt, S. I., Blaabjerg, M., Freude, K., & Meyer, M. (2022) · Cells · doi:10.3390/cells11091520 · Cited by 110 · see citing works
- Authors
- Mattii, L., Pardini, C., Ippolito, C., Bianchi, F., Sabbatini, A. R. M., & Vaglini, F.
- Affiliations
- University of Pisa (IT)
- Corresponding author
- Vaglini, Francesca
- Venue
- NeuroToxicology
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 72
- Pages
- 51-60
- ISSN
- 0161-813X (ISSN-L)
- OpenAlex
- W2913237658
- Cited by
- 9
- References
- 0
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 3
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- NeuroToxicology (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- PRA “Progetti di Ricerca di Ateneo” from the University of Pisa
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
- Keywords
- RhoA inhibition, rotenone, dopaminergic neurons, Parkinson's disease, neuroprotection, simvastatin, mitochondrial complex I inhibition, alpha-synuclein, dopamine uptake, connexin 43, actin
- MeSH terms
- Animals, Botulinum Toxins, Cells, Cultured, Rotenone, Neuroprotective Agents, Simvastatin, rhoA GTP-Binding Protein, Mice, Dopaminergic Neurons, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review